These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16965269)

  • 1. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo.
    Dell'anna ML; Picardo M
    Pigment Cell Res; 2006 Oct; 19(5):406-11. PubMed ID: 16965269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in vitiligo.
    Pietrzak A; Bartosińska J; Hercogová J; Lotti TM; Chodorowska G
    Dermatol Ther; 2012; 25 Suppl 1():S41-3. PubMed ID: 23237037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
    Lin X; Tian H; Xianmin M
    Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the unfolded protein response in vitiligo: the missing link?
    Passeron T; Ortonne JP
    J Invest Dermatol; 2012 Nov; 132(11):2502-4. PubMed ID: 23069909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the NKG2D in Vitiligo.
    Plaza-Rojas L; Guevara-Patiño JA
    Front Immunol; 2021; 12():624131. PubMed ID: 33717132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo: where do we stand?
    Ortonne JP; Bose SK
    Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B: Correlation with Active Vitiligo Depigmentation.
    Birlea SA
    J Invest Dermatol; 2017 Jul; 137(7):1408-1410. PubMed ID: 28647026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
    Gauthier Y; Cario Andre M; Taïeb A
    Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
    Cario-André M; Pain C; Gauthier Y; Taïeb A
    Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    Toosi S; Orlow SJ; Manga P
    J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
    Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
    J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo.
    Jimbow K; Chen H; Park JS; Thomas PD
    Br J Dermatol; 2001 Jan; 144(1):55-65. PubMed ID: 11167683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo.
    Kim JY; Lee EJ; Seo J; Oh SH
    Br J Dermatol; 2017 Jun; 176(6):1558-1568. PubMed ID: 27787879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.